The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rogal' E.Iu.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Bel'tsevich D.G.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Fadeev V.V.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Molashenko N.V.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Melnichenko G.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia;
Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia

Diagnosis of primary hyperaldosteronism

Authors:

Rogal' E.Iu., Bel'tsevich D.G., Fadeev V.V., Molashenko N.V., Melnichenko G.A.

More about the authors

Journal: Problems of Endocrinology. 2010;56(2): 47‑52

Views: 19802

Downloaded: 438

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Rogal' EIu, Bel'tsevich DG, Fadeev VV, Molashenko NV, Melnichenko GA. Diagnosis of primary hyperaldosteronism. Problems of Endocrinology. 2010;56(2):47‑52. (In Russ.)

МСФ на ЯМ
Close metadata

The present review is concerned with the problem of diagnosis of primary hyperaldosteronism and differential diagnosis of various nosological forms of this disease. Individual diagnostic steps are described along with main functional (verification) tests and instrumental methods used in the studies of this pathology.

Keywords:

primary hyperaldosteronism
aldosterone to renin ratio
verification test
comparative selective blood sampling from adrenal veins

Authors:

Rogal' E.Iu.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Bel'tsevich D.G.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Fadeev V.V.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Molashenko N.V.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Melnichenko G.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia;
Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia

List of references:

  1. Young W.F. Jr. Primary aldosteronism: management issues. Ann N Y AcadSci 2002; 970: 61-76.
  2. Hiramatsu K., Yamada T., Yukimura Y. et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Int Med 1981; 141: 1589-1593.
  3. Mulatero P., Stowasser M., Loh K.C. et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. Clin Endocrinol Metab 2004; 89: 1045-1050.
  4. Vetshev P.S., Shkrob O.S., Ippolitov L.I., Polunin G.V. Diagnostika i khirurgicheskoe lechenie arterial'nykh gipertenzii nadpochechnikovogo geneza. Khirurgiya 2001; 1: 33-40.
  5. Podzolkov V.I., Rodionov A.V. Pervichnyi giperal'dosteronizm: diagnostika i lechenie. Arterial'naya gipertenziya 2004; 10: 2.
  6. Young W.F.Jr., Klee G.G. Primary aldosteronism. Diagnostic evaluation. Endocrinology and Metabolism. Clin North Am 1988; 17: 367-395.
  7. Labinson P.T., White W.B., Tendler B.E., Mansoor G.A. Primary hyperaldosteronism associated with hypertensive emergencies. Am J Hypertens 2006; 9: 623-627.
  8. Blumenfeld J.D., Sealey J.E., Schlussel Y. et al. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1994; 121: 877-885.
  9. Pavlenko A.K., Fadeev V.V., Mel'nichenko G.A. Diagnostika pervichnogo giperal'dosteronizma. Probl endokrinol 2001; 2: 15-25.
  10. Rossi G.P., Bernini G., Caliumi C. et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-2300.
  11. Rossi G.P., Bernini G., Desideri G. et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 2006; 48: 232-238.
  12. Dedov I.I. Bolezni organov endokrinnoi sistemy. M: Meditsina 2000.
  13. D Khirurgiya nadpochechnikov. Pod red. A.P. Kalinina, N.A. Maistrenko. M 2000.
  14. Chikhladze N. Pervichnyi giperal'dosteronizm. Vrach 1992; 5: 21-23.
  15. An Endocrine Society Clinical Practice Guidelines. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism. J Clin Endocrinol Metab 2008; 93: 9: 3266-3281.
  16. McKenna T.J., Sequeira S.J., Heffernan A. et al. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosteroneaxis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991; 73: 952-957.
  17. Stowasser M., Gordon R.D., Gunasekera T.G. et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective' screening of hypertensive patients. J Hypertens 2003; 21: 2149-2157.
  18. Gallay B.J., Ahmad S., Xu L. et al. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001; 37: 699-705.
  19. Gordon R.D., Stowasser M., Tunny T.J. et al. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315-318.
  20. Lim P.O., Dow E., Brennan G. et al. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14: 311-315.
  21. Loh K.C., Koay E.S., Khaw M.C. et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85: 2854-2859.
  22. Tiu S.C., Choi C.H., Shek C.C. et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005; 90: 72-78.
  23. Young W.F. Jr. Primary aldosteronism: update on diagnosis and treatment. The Endocrinologist 1997; 7: 213-221.
  24. Young W.F. Jr. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007; 66: 607-618.
  25. Gordon R.D. The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens 2004; 22: 251-255.
  26. Kaplan N.M. The current epidemic of primary aldosteronism: causes and consequences. J Hypertens 2004; 22: 863-869.
  27. Schwartz G.L., Chapman A.B., Boerwinkle E. et al. Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clin Chem 2002; 48: 1919-1923.
  28. Rossi G.P., Rossi E., Pavan E. et al. Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol 1998; 49: 713-723.
  29. Kaplan N.M. Caution about the overdiagnosis of primary aldosteronism. Mayo Clin Proc 2001; 76: 875-876.
  30. Padfield P.L. Primary aldosteronism, a common entity the myth persists. J Hum Hypertens 2002; 16: 159-162.
  31. Gordon R.D., Stowasser M., Klemm S.A., Tunny T.J. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: J.D. Swales (ed.). Textbook of hypertension. London: Blackwell Scientific 1994; 865-892.
  32. Mulatero P., Dluhy R.G., Giacchetti G. et al. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005; 16: 114-119.
  33. Stowasser M., Gordon R.D., Rutherford J.C. et al. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2001; 2: 156-169.
  34. Hambling C., Jung T., Gunn A. et al. Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin Endocrinol 1992; 36: 499-503.
  35. Mulatero P., Bertello C., Garrone C. et al. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 2007; 50: e26-27.
  36. Muratani H., Abe I., Tomita Y. et al. Is single oral administration of captopril beneficial in screening for primary aldosteronism Am Heart J 1986; 112: 361-367.
  37. Mulatero P., Milan A., Fallo F. et al. Comparison of Confirmatory Tests for the Diagnosis of Primary Aldosteronism. J Clin Endocrinol Metab 2006; 91: 7: 2618-2623.
  38. Rossi G.P., Belfiore A., Bernini G. et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 2007; 50: 424-431.
  39. Espiner E.A., Ross D.G., Yandle T.G. et al. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 2003; 88: 3637-3644.
  40. Phillips J.L., Walther M.M., Pezzullo J.C. et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 2000; 85: 4526-4533.
  41. Ganguly A., Dowdy A.J., Luetscher J.A., Melada G.A. Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 1973; 36: 401-404.
  42. Gordon R.D., Gomez-Sanchez C.E., Hamlet S.M. et al. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl 1987; 5: S103-106.
  43. Vetshev P.S., Ippolitov L.I., Koroleva I.M., Kovalenko E.I. Vozmozhnosti komp'yuternoi tomografii v diagnostike novoobrazovanii nadpochechnikov. Khipypgiya 2002; 6: 9-14.
  44. Young W.F. Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007; 356: 601-610.
  45. Daunt N. Adrenal vein sampling: how to make it quick, easy, and successful. RadioGraphics 2005; 25: Suppl 1: S143-S158.
  46. Rossi G.P., Sacchetto A., Chiesura-Corona M. et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001; 86: 1083-1090.
  47. Kloos R.T., Gross M.D., Francis I.R. et al. Incidentally discovered adrenal masses. Endocr Rev 1995; 16: 460-484.
  48. Lingam R.K., Sohaib S.A., Rockall A.G. et al. Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome). Eur Radiol 2004; 14: 1787-1792.
  49. Lumachi F., Marzola M.C., Zucchetta P. et al. Non-invasive adrenal imaging in primary aldosteronism: sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun 2003; 24: 683-688.
  50. Gordon R.D. Diagnostic investigations in primary aldosteronism. In: A. Zanchetti (ed.). Clinical medicine series on hypertension. Maidenhead, UK: McGraw-Hill International 2001; 101-111.
  51. Nwariaku F.E., Miller B.S., Auchus R. et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 2006; 141: 497-502.
  52. Young W.F. Jr, Stanson A.W., Thompson G.B. et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-1235.
  53. Gross M.D., Shapiro B., Shreve P. Radionuclide imaging of the adrenal cortex. Q J Nucl Med 1999; 43: 224-232.
  54. Nakahama H., Fukuchi K., Yoshihara F. et al. Efficacy of screening for primary aldosteronism by adrenocortical scintigraphy without discontinuing antihypertensive medication. Am J Hypertens 2003; 16: 725-728.
  55. Nocaudie-Calzada M., Huglo D., Lambert M. et al. Efficacy of iodine-131 6beta-methyl-iodo-19-nor-cholesterol scintigraphy and computed tomography in patients with primary aldosteronism. Eur J Nucl Med 1999; 26: 1326-1332.
  56. Nomura K., Kusakabe K., Maki M. et al. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab 1990; 71: 825-830.
  57. Mansoor G.A., Malchoff C.D., Arici M.H. et al. Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning. Am J Hypertens 2002; 15: 459-464.
  58. Biglieri E.G., Schambelan M. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab 1979; 49: 87-91.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.